Latest News about MDGL
Recent news which mentions MDGL
From Benzinga
From Benzinga
Billionaire Investor Buys Google And This Gold Miner Stock
August 16, 2025
From Benzinga
Earnings Scheduled For August 5, 2025
August 05, 2025
From Benzinga
European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug
June 20, 2025
From Benzinga
From Benzinga
From Motley Fool
Earnings Scheduled For May 1, 2025
May 01, 2025
From Benzinga
From Benzinga
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
February 26, 2025
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 26, 2025
From Benzinga
Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver Cirrhosis
February 26, 2025
From Benzinga
Earnings Scheduled For February 26, 2025
February 26, 2025
From Benzinga
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
From Benzinga
Why Madrigal Pharmaceuticals Stock Was Plummeting This Week
January 17, 2025
Tickers
MDGL
From Motley Fool
Top 3 Health Care Stocks That May Dip This Month
November 25, 2024
From Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
From Motley Fool
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
November 23, 2024
Tickers
MDGL
From Motley Fool
Tickers
MDGL
From Motley Fool
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
From Benzinga
Is Madrigal Pharmaceuticals Stock a Buy?
August 17, 2024
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.